BOTULISM ANTITOXIN HEPTAVALENT

BOTULISM ANTITOXIN HEPTAVALENT was reported 129 times

BOTULISM ANTITOXIN HEPTAVALENT is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 EUTHYROID SICK SYNDROME 1 0.0118
1 PRODUCT WITH QUALITY ISSUE ADMINISTERED 5 0.0112
2 NEUROMUSCULAR TOXICITY 2 0.0057
3 SERUM SICKNESS-LIKE REACTION 2 0.0032
4 DEVICE PROGRAMMING ERROR 1 0.0032
5 WEANING FAILURE 1 0.0027
6 PNEUMONIA HAEMOPHILUS 1 0.0021
7 PUPILLARY DISORDER 1 0.0016
8 WRONG DEVICE USED 1 0.0015
9 RESPIRATORY TRACT OEDEMA 1 0.0013
10 TRACHEOBRONCHITIS 1 0.0013
11 PROCEDURAL HYPOTENSION 1 0.0012
12 PRODUCT TEMPERATURE EXCURSION ISSUE 5 0.0010
13 INCORRECT DRUG ADMINISTRATION RATE 3 0.0007
14 PNEUMATOSIS INTESTINALIS 2 0.0007
15 ACUTE ABDOMEN 1 0.0007
16 PNEUMONIA KLEBSIELLA 1 0.0005
17 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 1 0.0004
18 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
19 STRIDOR 1 0.0003
20 PNEUMONIA ASPIRATION 8 0.0003
21 BRADYCARDIA 14 0.0003
22 HAEMODYNAMIC INSTABILITY 2 0.0003
23 HYPERURICAEMIA 1 0.0002
24 PULSELESS ELECTRICAL ACTIVITY 1 0.0002
25 ANAPHYLACTIC REACTION 13 0.0002
26 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
27 ILEUS PARALYTIC 1 0.0002
28 THERAPEUTIC PRODUCT EFFECT DELAYED 1 0.0002
29 DISEASE COMPLICATION 1 0.0002
30 BRAIN INJURY 2 0.0002
31 TACHYCARDIA 16 0.0002
32 PRODUCT LABEL CONFUSION 1 0.0002
33 HYPERTRIGLYCERIDAEMIA 1 0.0002
34 BLOOD PRESSURE FLUCTUATION 4 0.0002
35 HYDRONEPHROSIS 1 0.0001
36 ATELECTASIS 1 0.0001
37 SINUS BRADYCARDIA 1 0.0001
38 BODY TEMPERATURE DECREASED 1 0.0001
39 HYPOTHERMIA 1 0.0001
40 CARDIO-RESPIRATORY ARREST 4 0.0001
41 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
42 EPISTAXIS 7 0.0001
43 BLOOD PRESSURE DECREASED 6 0.0001
44 NEPHROPATHY TOXIC 1 0.0001
45 CEREBRAL INFARCTION 2 0.0001
46 TACHYPNOEA 1 0.0001
47 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
48 PNEUMONIA 22 0.0001
49 HYPOAESTHESIA ORAL 1 0.0001
50 VENTRICULAR TACHYCARDIA 1 0.0001
51 UPPER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
52 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
53 LEUKOCYTOSIS 1 0.0001
54 PRODUCT ADMINISTRATION ERROR 1 0.0000
55 PYREXIA 17 0.0000
56 LIVER FUNCTION TEST INCREASED 1 0.0000
57 HEART RATE IRREGULAR 1 0.0000
58 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
59 SHOCK 1 0.0000
60 HYPERSENSITIVITY 8 0.0000
61 CARDIAC ARREST 3 0.0000
62 RESPIRATORY ARREST 1 0.0000
63 RESPIRATORY DISTRESS 1 0.0000
64 ACUTE MYOCARDIAL INFARCTION 1 0.0000
65 DRUG ADMINISTRATION ERROR 1 0.0000
66 NIGHT SWEATS 1 0.0000
67 EXPIRED PRODUCT ADMINISTERED 1 0.0000
68 URINARY RETENTION 1 0.0000
69 HYPOXIA 1 0.0000
70 RESPIRATORY FAILURE 2 0.0000
71 BLOOD PRESSURE INCREASED 4 0.0000
72 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
73 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
74 HYPOTENSION 5 0.0000
75 EXTRA DOSE ADMINISTERED 1 0.0000
76 NEUTROPHIL COUNT DECREASED 1 0.0000
77 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
78 PULMONARY OEDEMA 1 0.0000
79 ADVERSE EVENT 2 0.0000
80 COMA 1 0.0000
81 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
82 OXYGEN SATURATION DECREASED 1 0.0000
83 URINARY TRACT INFECTION 3 0.0000
84 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
85 ANAEMIA 3 0.0000
86 DEEP VEIN THROMBOSIS 1 0.0000
87 INFUSION RELATED REACTION 1 0.0000
88 HYPERTENSION 3 0.0000
89 AGITATION 1 0.0000
90 ACUTE KIDNEY INJURY 2 0.0000
91 CARDIAC FAILURE CONGESTIVE 1 0.0000
92 DRY MOUTH 1 0.0000
93 PRODUCT STORAGE ERROR 1 0.0000
94 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
95 DEATH 9 0.0000
96 CHEST DISCOMFORT 1 0.0000
97 ABDOMINAL DISTENSION 1 0.0000
98 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
99 SEIZURE 1 0.0000
100 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
101 HYPERHIDROSIS 1 0.0000
102 HYPOAESTHESIA 1 0.0000
103 PARAESTHESIA 1 0.0000
104 TOXICITY TO VARIOUS AGENTS 1 0.0000
105 NO ADVERSE EVENT 1 0.0000
106 RASH 2 0.0000
107 CONSTIPATION 1 0.0000
108 INCORRECT DOSE ADMINISTERED 1 0.0000
109 ABDOMINAL PAIN 1 0.0000
110 DYSPNOEA 2 0.0000
111 PRURITUS 1 0.0000
112 OFF LABEL USE 2 0.0000
113 DRUG INEFFECTIVE 3 0.0000
114 DIZZINESS 1 0.0000